• FDA Approves GATTEX® for Children with Short Bowel Syndrome americanpharmaceuticalreview
    May 23, 2019
    Takeda Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved extending the indication of GATTEX® (teduglutide) for injection to pediatric patients 1 year of age and older with ...
PharmaSources Customer Service